A Multicenter Selective Screening Study to Investigate the Frequency of Neuronal Ceroid Lipofuxinosis Type 2 (CLN2)
Recruiting
Observational Study
Neuronal Ceroid Lipofuxinosis Type2 (CLN2)
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 2 – 6
- Sex
- Any
- Study type
- Observational
- Participants needed
- 750 (estimated)
- Sponsor
- Nadir Hastalıkları Araştırma Derneği · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is a multicenter, non-drug screening study. Enrollment period is 12 months. There are no IMP to be followed or used in the study. Patients who applied to Pediatric Metabolism, Pediatric Neurology and Developmental Pediatrics clinics with the symptoms or findings defined in the protocol as below for 12 months will be included in the study.
Children between the ages of 2 and 6, without h…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Girls and boys aged 6 years old
* Having a history of at least one seizure
* With a history of idiopathic seizures;
* Speech disorder or regression in acquired speaking skills,
* Motor dysfunctions,
* Photoparoxysmal response to EEG with low-frequency IFS,
* Observati…
Contacts